Sign inJoin waitlistJoin the waitlist

Wendel Naumann

Co-Leader · Wake Forest University Baptist Medical Center

Credentials: · · · ·

History

Wake Forest University Baptist Medical Center
Present
Wake Forest University Baptist Medical Center
Present

Gynecologic Oncology
University of Alabama Hospital
1995–1998
Obstetrics and Gynecology
University of Alabama Hospital
1991–1995
The University of Alabama at Birmingham
University of Alabama at Birmingham School of Medicine
1984–1988

Research

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
Journal of Clinical Oncology · 2019 · First of 19 authors · Corresponding · 351 citations
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer
Journal of Clinical Oncology · 2007 · 335 citations
PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant…
Journal of Clinical Oncology · 2013 · First of 20 authors · 168 citations

Jubilee Brown
26 papers
DT
David Tait
13 papers
Erin Crane
13 papers · 4 as a resident
Robert Higgins
13 papers
Ronald Alvarez
9 papers
JH
James Hall
8 papers
RC
Robert Coleman
8 papers
Edward Partridge
7 papers
Kathleen Moore
7 papers
Lane Drury
6 papers
Larry Kilgore
5 papers · 1 as a fellow
Thomas Herzog
5 papers

Clinical trials

A Study Evaluating the Effect of Frozen-Section Directed Excision Surgery on Vulvar Dysplasia
Principal investigator · Active not recruiting
Wake Forest University Health Sciences
2023–2026
Study of SGR-3515 In Participants With Advanced Solid Tumors.
Site PI · Recruiting · Phase 1
Schrödinger, Inc.
2024–2026